The goal of this pilot randomized crossover feasibility trial is to determine the feasibility of a short-term, culture-tailored, plant-based dietary behavior intervention and examine the preliminary outcomes regarding inflammation and metabolic markers in generally healthy adults. The main questions it aimed to answer were: Are the trial design and corresponding outcomes, including recruitment rate, retention rate, meal delivery completion, participant satisfaction, and adverse event occurrence feasible for a future definitive study? Are the clinical outcomes were examined as preliminary secondary endpoints able to generate effect size estimates for future study planning? Participants were: Randomly allocated to group PBD (plant-based diet)-GD (general diet) or group GD-PBD. Group PBD-GD completed the 2-week PBD stage first, crossed over after the 1-week washout period, then completed the 2-week GD stage. Group GD-PBD followed the reverse sequence. Instructed to record their daily dietary intake throughout both stages in a mobile food diary application. Invited to visit the trial venue for the measurements at four time points: before and after each stage.
Background Despite growing evidence for PBD's anti-inflammatory effects, few studies have examined its feasibility and short-term efficacy within a culturally specific, real-world dietary context, particularly in East Asian populations. The current pilot randomized crossover feasibility trial aimed to determine the feasibility of a short-term, culture-tailored, and plant-based dietary behavior intervention and its preliminary outcomes regarding inflammation and metabolic markers. Methods The randomized, single-blinded crossover feasibility trial was conducted at a regional general hospital in eastern Taiwan. Participants were randomly allocated to group PBD-GD or group GD-PBD using a computer-generated random number sequence. After 2-week intervention followed by 1-week washout period, participants were crossed over to the other group for the subsequent 2-week intervention. During the dietary intervention, lunch and dinner were provided by local commercial restaurants during weekdays based on assigned stage. Primary outcome, high-sensitivity C-reactive protein (Hs-CRP), along with the secondary outcomes, interleukin-6 (IL-6), IL-10, low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), and triglycerides (TG) were measured before and after each intervention, at week 0, 2, 3, and 4. Adherence was supported through two platforms, an anonymous group messaging platform and a mobile food diary application.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
30
Lunch and dinner were provided on workdays according to the assigned dietary stage, as boxed takeout meals prepared by local restaurants or catering companies. Deliveries were scheduled to arrive at the study hospital between 12:00 and 12:30 for lunch and 17:00 and 17:30 for dinner. A research assistant was to coordinate and contact the local restaurants for meal delivery an hour before the planned schedule. Participants were instructed to collect their meals from the research office before 12:30 and 17:30, respectively.
Lunch and dinner were provided on workdays according to the assigned dietary stage, as boxed takeout meals prepared by local restaurants or catering companies. Deliveries were scheduled to arrive at the study hospital between 12:00 and 12:30 for lunch and 17:00 and 17:30 for dinner. A research assistant was to coordinate and contact the local restaurants for meal delivery an hour before the planned schedule. Participants were instructed to collect their meals from the research office before 12:30 and 17:30, respectively.
Hualien Amed Forces General hospital
Hualien City, Taiwan
Retention rate (%)
The number of participants included in the final analysis divided by the total number of participants enrolled
Time frame: At week 0 and week 5
Meal Delivery Completion Rate (%)
The number of meal deliveries received within the designated time window divided by the total number of scheduled meal deliveries across the intervention period
Time frame: Period of Meal Provision, at week 1-2 and week 4-5
Satisfaction score (mean score)
A score of 3.0 of each item on a 5-point Likert scale was utilized as the minimal criterion for acceptability
Time frame: At each post-stage timepoint, week 2 and week 5
Adverse Events (event count)
Particular attention to food safety and the individual tolerability of the dietary changes
Time frame: Throughout the intervention periond, from week 1 to week 5
High-sensitivity C-reactive protein (Hs-CRP, mg/L)
Physiological Inflammatory Indicator
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
Interleukin-6 (IL-6, pg/mL)
Physiological Pro-Inflammatory Indicator
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
Interleukin-10 (IL-10, pg/mL)
Physiological Anti-Inflammatory Indicator
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.